Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06384456 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Topical TRanexamic Acid vs. Placebo on Acute Postoperative Pain Following DRF Fixation

Study acronym: TRADR
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Mar 2025 to Aug 13, 2025 · Primary completion date: Jun 2026 to Dec 2026 · Completion date: Sep 2026 to Dec 2027 · 1 morev4 Show 4 more changesShow less
    • Start date changed from estimate of Mar 2025 to Aug 13, 2025
    • Primary completion date: Jun 2026 to Dec 2026
    • Completion date: Sep 2026 to Dec 2027
    • Site details revised
  2. Start date: Aug 2024 to Mar 2025v3
  3. Eligibility criteria shortened, about 11 wordsv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to find out whether the use of topical tranexamic acid (TXA) into the surgical wound will result in less post-operative pain, less pain killer use, and better post-operative use of the wrist in people undergoing surgery for a wrist fracture compared to not using topical TXA (placebo).
Trial Details
NCT Number NCT06384456
Lead Sponsor University Health Network, Toronto
Conditions Distal Radius Fractures
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov